| Reference | FOI2026/2091 |
|---|---|
| Description | Guidelines on the Treatment of Interstitial Lung Diseases (ILD) |
| Date Requested | 12/10/2026 |
| Date Replied | 19/10/2026 |
| Category | Medicines Optimisation |
Please find below a freedom of information request relating to clinical guidelines for the treatment of interstitial lung diseases (ILD).
This request is in follow up to a previous related request submitted in April 2023 and has been prompted by recent developments in the treatments of these conditions.
Question 1
| Has NHS Greater Manchester ICB published or updated any local treatment guidelines, pathways or protocols for the treatment of the interstitial lung diseases (ILD), idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) since April 2023? | Yes/No |
| If Yes, please provide a copy. | |
All Greater Manchester ICB medicines guidelines, pathways and protocols are publicly available on the Greater Manchester Medicines Management Group (GMMMG) website which can be accessed via: https://gmmmg.nhs.uk/